Related Experiment Videos

Low normal level of protein C or of antithrombin increases risk for recurrent cardiovascular events

K Markus Pelkonen1, Ulla Wartiovaara-Kautto, Markku S Nieminen

  • 1Department of Medicine, Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland. markuspelkonen@suomi24.fi

Insights

Lower levels of protein C (PC) and antithrombin (AT) in acute coronary syndrome patients predict higher risk of recurrent cardiovascular events. These haemostatic factors are crucial for assessing long-term prognosis.

Area of Science:

  • Cardiovascular Medicine
  • Haematology
  • Clinical Research

Background:

  • Acute coronary syndrome (ACS) patients face a significant risk of recurrent cardiovascular events.
  • Haemostatic factors play a critical role in thrombotic processes underlying ACS.
  • The predictive value of specific haemostatic factors for long-term outcomes in ACS is not fully elucidated.

Purpose of the Study:

  • To investigate the relationship between haemostatic factors and recurrent cardiovascular events in ACS patients.
  • To assess the prognostic significance of measured haemostatic parameters for cardiovascular endpoints.

Main Methods:

  • A cohort of 115 ACS patients (acute non-Q myocardial infarction or unstable angina) was studied.
  • Haemostatic parameters including antithrombin (AT), protein C (PC), and others were measured serially over one year.
  • Patients were followed for major adverse cardiovascular events (MACE) for an average of 555 days.

Main Results:

  • Lower levels of PC and AT were observed in patients experiencing recurrent cardiovascular events compared to those without.
  • Low PC levels (<100%) at enrollment were associated with a 2.72-fold increased odds of experiencing an endpoint.
  • Reduced AT and PC levels throughout follow-up correlated with shorter event-free survival times.

Conclusions:

  • Lower concentrations of protein C and antithrombin, even within normal ranges, are associated with an elevated risk of recurrent cardiovascular events in ACS patients.
  • These haemostatic factors may serve as valuable biomarkers for predicting long-term prognosis and event-free survival in ACS.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...